Agonist actions of neonicotinoids on nicotinic acetylcholine receptors expressed by cockroach neurons.
The agonist actions of seven commercial neonicotinoid insecticides and nicotine were studied on nicotinic acetylcholine receptors (nAChRs) expressed by neurons isolated from the three thoracic ganglia of the American cockroach, Periplaneta americana. Single electrode voltage clamp recording was used to measure agonist-induced inward currents. Acetylcholine, nicotine and all neonicotinoids tested, except thiamethoxam, caused inward currents which were blocked reversibly by methyllycaconitine, a nAChR antagonist. Based on maximum inward currents, neonicotinoids could be divided into two subgroups: (1) those with a heterocyclic ring in their electronegative pharmacophore moiety (i.e. nicotine, imidacloprid and thiacloprid) were relatively weak partial agonists causing only 20-25% of the maximum ACh current and (2) open chain compounds (i.e. acetamiprid, dinotefuran, nitenpyram, and clothiandin) which were much more effective agonists producing 60-100% of the maximum ACh current. These compounds also elicited different symptoms of poisoning in American cockroaches with excitatory responses evident for the low efficacy agonists but depressive and paralytic responses predominating for the most efficacious agonists. No correlation was observed between agonist affinity and efficacy on these nAChRs. Thiamethoxam, even at 100 microM, failed to cause an inward current and showed no competitive interaction with other neonicotinoids on nAChRs, indicating that it is not a direct-acting agonist or antagonist. Despite the probable presence of multiple subtypes of nAChRs on cockroach neurons, competition studies between neonicotinoids did not reveal evidence that separate binding sites exist for the tested compounds. The size of inward currents induced by co-application of neonicotinoid pairs at equal concentration (100 microM) were predominantly determined by the one with higher binding affinity as indicated by EC(50) values, rather than by the one with higher binding efficacy as indicated by maximal current (I(max)). Agonist efficacy, but not affinity, was positively correlated with insecticidal activity. These findings indicate that: (1) agonist affinity and efficacy vary independently with neonicotinoid structure; (2) high agonist efficacy is dependent on the presence of an acyclic electronegative pharmacophore group; (3) agonist efficacy is a significant factor in the insecticidal activity of neonicotinoids to cockroaches; (4) lower efficacy compounds cause excitatory symptoms (Type A), while high efficacy compounds cause depressive/paralytic symptoms (Type B).
Tan
Jianguo
J
Department of Entomology, Michigan State University, East Lansing, MI 48824, USA.
Galligan
James J
JJ
Hollingworth
Robert M
RM
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D003058:Cockroaches; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D017952:Ganglia, Invertebrate / Q000166:cytology; D015870:Gene Expression / Q000187:drug effects*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009474:Neurons / Q000187:drug effects*; D018722:Nicotinic Agonists / Q000737:chemistry* / Q000494:pharmacology*; D018408:Patch-Clamp Techniques / Q000379:methods; D011978:Receptors, Nicotinic / Q000378:metabolism*
D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D000109:Acetylcholine